MedPath
HSA Approval

Difflam For Children Throat Spray

SIN13626P

Difflam For Children Throat Spray

Difflam For Children Throat Spray

April 2, 2009

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Licence HolderINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SPRAY

**How to use Difflam® For Children Throat Spray** Adults and children over 12 years: 4–8 sprays (1–2 mg) directly onto the sore/inflamed area and swallow gently. Repeat every 1½ to 3 hours as necessary. Children (6–12 years): 4 sprays (1 mg) directly onto sore/inflamed area and swallow gently. Repeat every 1½ to 3 hours as necessary. Children under 6 years: Not recommended. Uninterrupted treatment should not exceed seven days, unless under medical supervision. _Cleaning Instructions:_ After use, wipe the nozzle with a clean tissue to prevent blockage.

BUCCAL

Medical Information

**What Difflam® For Children Throat Spray is used for** Difflam® For Children Throat Spray is used for relief from the symptoms of tonsilitis, sore throat, mouth ulcers, pharyngitis, swelling, redness and inflammatory conditions, pain following mouth or throat surgery and pain following dental procedures.

**Contraindications** Patients with known hypersensitivity to benzydamine hydrochloride or to any other ingredients present in Difflam® For Children Throat Spray.

A01AD02

benzydamine

Manufacturer Information

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Aziende Chimiche Riunite Angelini Francesco S.p.A.

Active Ingredients

Benzydamine hydrochloride

1.5mg/mL

Benzydamine

Documents

Patient Information Leaflets

Difflam PIL March 2023.pdf

Approved: March 9, 2023

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.